Flotillin-2: A new potential predictor for prognosis of breast cancer
Sascha Pust, first author
Overexpression of ErbB2 occurs in up to 30% of human breast cancers. ErbB2 is not down-regulated by ligand-induced mechanisms as many other receptors. In a new study now published in Oncogene (journal impact factor 6.4), Sascha Pust (photo) from Kirsten Sandvig's group at the Institute for Cancer Research and coworkers show that flotillins stabilize ErbB2 at the plasma membrane. Moreover, microarray analysis of biopsies of 194 breast cancer patients indicated that flotillin-2 is a good prognostic marker for breast cancer. Depletion of flotillins leads to internalization and degradation of ErbB2, thereby inhibiting the ErbB2-triggered signaling.
This study was a collaboration between several groups, including three groups (Sandvig, Danielsen, Liestøl) from the Center for Cancer Biomedicine (CCB).
From major journals, first or last author from the Institute for Cancer Research
Parissenti AM, Pritzker LB, Dahle MA, Gythfeldt HVL, Masilamani T, Theriault G, St-Onge R, D'costa L, Lingjaerde OC, Haugen MH, Engebraaten O(2025) High mid-treatment tumour RNA disruption in patients with HER2-negative breast cancer is associated with improved disease-free survival after neoadjuvant chemotherapy Breast Cancer Res, 27(1), 143 DOI 10.1186/s13058-025-02092-9, PubMed 40790765
Brodal HP, Pharo H, Vedeld HM, Lind GE(2025) PoDCall: a robust tool for automated droplet classification in DNA-methylation droplet digital PCR Mol Oncol(in press) DOI 10.1002/1878-0261.70105, PubMed 40761129
Radulovic M, Yang C, Stenmark H(2025) Lysosomal membrane homeostasis and its importance in physiology and disease Nat Rev Mol Cell Biol(in press) DOI 10.1038/s41580-025-00873-w, PubMed 40759742
Sagini K, Selvarajah M, Romero S, Bassols-Citores E, Martin-Gracia B, Ramirez-Garrastacho M, Rise F, Endzeliņš E, Sadovska L, Skorinkina D, Boguševiča M, Cešeiko R, Čampa M, Klavina A, Linē A, Llorente A(2025) The Redox Enzyme Thioredoxin Is Increased in Plasma Extracellular Vesicles From Endurance-Trained Females in Response to Acute Exercise FASEB J, 39(16), e70927 DOI 10.1096/fj.202500678R, PubMed 40810354
Stamnaes J, Stray D, du Pré MF, Risnes LF, Dewan AE, Shaik J, Stensland M, Lundin KE, Sollid LM(2025) Interferon-γ is a direct driver of crypt hyperplasia in celiac disease J Clin Invest(in press) DOI 10.1172/JCI194858, PubMed 40828615
Nassar AH, Kim C, Adeyelu T, Bou Farhat E, Abushukair H, Rakaee M, Matteson K, Lau SF, Takabe Y, Ocejo A, Ardeshir-Larijani F, Leal T, Ramalingam S, Alam S, Gray JE, Hicks J, Kaldas D, Baena J, Berjaga MZ, Nana FA, Grohe C, Leuders H, Citarella F, Cortellini A, Mingo ECet al.(2025) Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma Nat Commun, 16(1), 7717 DOI 10.1038/s41467-025-63091-0, PubMed 40830141